Eleos, a Boston and Tel Aviv-based company that offers AI-powered solutions for behavioral health, has raised $60 million in Series C funding.
Investors
The round was led by Greenfield Partners, with support from F-Prime Capital, Eight Roads, Menlo Ventures, ION, and new investors, including the Michael & Susan Dell Foundation, Union Tech Ventures, and Centerstone. This round brings Eleos' total funding to over $120 million.
Greenfield invests in disruptive technology and tech-enabled businesses globally at the early growth stage, then applies its Greenfield Growth Momentum (G2M) playbooks to implement best-in-class go-to-market practices that accelerate the path to global scale. Having spun out of TPG Growth in 2020, Greenfield independently manages over $1 billion across its portfolio today.
Eleos Use of Funds
The company plans to use the funds to expand its product offerings, grow its commercial team, and target underserved areas, including substance use disorder (SUD) treatment centers.
About Eleos
Eleos specializes in artificial intelligence (AI) solutions for behavioral health. Its AI platform is designed to help behavioral health providers reduce administrative burdens, improve clinical documentation, and enhance patient engagement. Its solutions, widely deployed across the U.S., serve over 120 organizations in more than 30 states.
Funding Details
Company: Eleos Health, Inc.
Raised: $60.0M
Round: Series C
Funding Date: January 2025
Lead Investor: Greenfield Partners
Additional Investors: F-Prime Capital, Eight Roads, Menlo Ventures, ION, Michael & Susan Dell Foundation, Union Tech Ventures, Centerstone
Company Website: https://eleos.health/
Software Category: Behavioral Health AI
Source: https://www.businesswire.com/news/home/20250122573635/en/